-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
April 01, 2025 - Making Healthcare Safer IV Rapid Review: Supply Chain Disruption Monitoring Programs
Making Healthcare Safer IV
Supply Chain Disruption Monitoring
Programs
Rapid Review
Structured Abstract
Objectives. To summarize recent relevant literature on supply chain disruption
monitoring programs in healthcare se…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
June 16, 2022 - Disposition of Comments_Comparative Effectiveness Review No. 256: Effectiveness of Telehealth for Women's Preventive Services
Comparative Effectiveness Review Disposition of Comments Report
Title: Effectiveness of Telehealth for Women’s Preventive Services
Draft report available for public comment…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
January 01, 2016 - 9 32 NA 7 34 NA
McCall, 2008 3 SGA Intubating laryngeal mask airway (ILMA), Laryngeal Mask Airway Company … 42 10 NA 26 20 NA
McCall, 2008 3 SGA Intubating laryngeal mask airway (ILMA), Laryngeal Mask Airway Company … html], pharyngeal-cuff-type esophageal obstructive airway [New EOA; Sumiway WB®, Sumitomo Bakelite Company
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
April 25, 2013 - Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Pulmonary Arterial Hypertension: Screening, Management, and
Treatment
Draft review available for public commen…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-future_research.pdf
February 01, 2013 - Template for Draft Reports
Future Research Needs Paper
Number 37
Physical Therapy for
Knee Pain Secondary to
Osteoarthritis: Future
Research Needs
Future Research Needs Paper
Number 37
Physical Therapy for Knee Pain Secondary to
Osteoarthritis: Future Research Needs
Identification of Future Research …
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Covidien, plc (Dublin, Ireland), 510(k) clearance for the Cytosponge in November 2014 before the
company
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/primary-research-design_research.pdf
January 01, 2012 - New York: WH Freeman and
Company; 1986.
17. Knipschild P. Systematic reviews: some
examples.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
February 01, 2012 - sites of genes
are hypermethylated leading to suppression of gene
transcription.7
Thus far a single company
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - the phase III BROADEN (Brodmann Area 25 Deep
Brain Neurostimulation).
20
According to a July 2011 company
-
effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
January 01, 2012 - Popchilla is a
small, emotionally expressive interactive robot developed by Interbots, a spin-off company
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - For instance, a company that offers a well-used test that produces dichotomous, qualitative results —
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - For instance, a company that offers a well-used test that produces dichotomous, qualitative results —
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - Saunders Company; 1999:543-99.
7. Lloyd-Jones D, Adams RJ, Brown TM, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
December 11, 2012 - Administration
FDA Status UA/NSTEMI-Related FDA
Indications
Angiomax®
Bivalirudin The Medicines
Company
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
December 01, 2011 - Layout 1
Background
Depressive disorders such as major
depressive disorder (MDD), dysthymia,
and subsyndromal depression (including
minor depression) may be serious disabling
illnesses. MDD is the most prevalent,
affecting more than 16 percent (lifetime) of
U.S. adults. In 2000, the U.S. economic
burden of depressiv…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
April 28, 2010 - Source: www.effectivehealthcare.ahrq.gov
Published Online: July 21, 2011
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Screening, Behavioral Counseling, and Referral in Primary Care to Reduce
Alcohol Misuse
Amendment Date(s) if applicable: Not applicable
(Amendments Detail…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: The Effectiveness of Disease-modifying Anti-rheumatic drugs
(DMARDs) in Children with Juvenile Idio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - Disposition of Comments Report for Comparative Effectiveness Review No. 131
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Pharmacologic Therapies for the Management of Crohn’s Disease:
Comparative Effectiveness
Draft review available for public commen…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
May 13, 2014 - is worth noting that the larger study used in
the meta-analysis was sponsored by a pharmaceutical company
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
May 20, 2013 - Response: Saad reports in his technical review of the
wireless motility capsule10 the company guidelines … This guideline was developed by
the company from a review of their clinical study data and
from potentially